Alimentary Pharmacology & Therapeutics

Current therapeutic options for gastric antral vascular ectasia
pp. 157-165(9)
Authors: Sebastian, S.; O'Morain, C. A.; Buckley, M. J. M.

Does gall-bladder ejection fraction on cholecystokinin cholescintigraphy predict outcome after cholecystectomy in suspected functional biliary pain?
pp. 167-174(8)
Authors: Delgado-Aros, S.; Cremonini, F.; Bredenoord, A. J.; Camilleri, M.

Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre study
pp. 175-181(7)
Authors: Gornet, J.-M.; Couve, S.; Hassani, Z.; Delchier, J.-C.; Marteau, P.; Cosnes, J.; Bouhnik, Y.; Dupas, J.-L.; Modigliani, R.; Taillard, F.; Lemann, M.

High variation of tioguanine absorption in patients with chronic active Crohn's disease
pp. 183-189(7)
Authors: Deibert, P.; Dilger, K.; Fischer, C.; Hofmann, U.; Nauck, S.; Stoelben, S.; Kreisel, W.

Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease
pp. 191-198(8)
Authors: Shale, M. J.; Riley, S. A.

Differential effects of baclofen on lower oesophageal sphincter pressure and proximal gastric motility in humans
pp. 199-207(9)
Authors: Lee, K.-J.; Vos, R.; Janssens, J.; Tack, J.

Antibiotic prophylaxis for percutaneous endoscopic gastrostomy — a prospective, randomised, double-blind trial
pp. 209-215(7)
Authors: Ahmad, I.; Mouncher, A.; Abdoolah, A.; Stenson, R.; Wright, J.; Daniels, A.; Tillett, J.; Hawthorne, A. B.; Thomas, G.

Economic analysis of celecoxib versus diclofenac plus omeprazole for the treatment of arthritis in patients at risk of ulcer disease
pp. 217-222(6)
Authors: Lee, K. K. C.; You, J. H. S.; Ho, J. T. S.; Suen, B. Y.; Yung, M. Y.; Lau, W. H.; Lee, V. W. Y.; Sung, J. Y.; Chan, F. K. L.

What is the long-term outcome of the different subgroups of functional dyspepsia?
pp. 223-229(7)
Authors: Heikkinen, M.; Färkkilä, M.

Coeliac disease presenting with symptoms of irritable bowel syndrome
pp. 231-235(5)
Authors: Shahbazkhani, B.; Forootan, M.; Merat, S.; Akbari, M. R.; Nasserimoghadam, S.; Vahedi, H.; Malekzadeh, R.

Preliminary evaluation of an injectable anal sphincter bulking agent (Durasphere) in the management of faecal incontinence
pp. 237-243(7)
Authors: Davis, K.; Kumar, D.; Poloniecki, J.

The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis
pp. 245-252(8)
Authors: Kamada, T.; Haruma, K.; Hata, J.; Kusunoki, H.; Sasaki, A.; Ito, M.; Tanaka, S.; Yoshihara, M.